OrthoPediatrics Corp. (NASDAQ: KIDS) Stock Competitors & Peer Comparison
See KIDS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for KIDS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KIDS | $21.82 | +0.18% | 560.4M | -18.49 | -$1.18 | N/A |
| ABT | $102.61 | +0.37% | 177.4B | 19.68 | $5.21 | +2.42% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $92.13 | -0.69% | 118B | 16.66 | $5.53 | +3.08% |
| SYK | $275.12 | -1.79% | 105.4B | 20.54 | $13.39 | +1.26% |
| BSX | $43.34 | -0.48% | 64.5B | 14.00 | $3.10 | N/A |
| EW | $88.26 | +0.01% | 50.8B | 32.69 | $2.70 | N/A |
| DXCM | $89.35 | +1.61% | 33.7B | 35.04 | $2.55 | N/A |
| GEHC | $64.13 | -0.49% | 29B | 14.06 | $4.56 | +0.22% |
| PHG | $24.68 | +0.00% | 24.1B | 14.10 | $1.75 | +4.01% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
KIDS vs ABT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ABT has a market cap of 177.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ABT trades at $102.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ABT's P/E ratio is 19.68. In terms of profitability, KIDS's ROE is -0.12%, compared to ABT's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
KIDS vs BSX-PA Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, KIDS's ROE is -0.12%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, KIDS is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
KIDS vs MDT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, MDT has a market cap of 118B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while MDT trades at $92.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas MDT's P/E ratio is 16.66. In terms of profitability, KIDS's ROE is -0.12%, compared to MDT's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
KIDS vs SYK Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SYK has a market cap of 105.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SYK trades at $275.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SYK's P/E ratio is 20.54. In terms of profitability, KIDS's ROE is -0.12%, compared to SYK's ROE of +0.16%. Regarding short-term risk, KIDS is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
KIDS vs BSX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BSX has a market cap of 64.5B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BSX trades at $43.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BSX's P/E ratio is 14.00. In terms of profitability, KIDS's ROE is -0.12%, compared to BSX's ROE of +0.15%. Regarding short-term risk, KIDS is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
KIDS vs EW Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, EW has a market cap of 50.8B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while EW trades at $88.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas EW's P/E ratio is 32.69. In terms of profitability, KIDS's ROE is -0.12%, compared to EW's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
KIDS vs DXCM Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, DXCM has a market cap of 33.7B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while DXCM trades at $89.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas DXCM's P/E ratio is 35.04. In terms of profitability, KIDS's ROE is -0.12%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, KIDS is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
KIDS vs GEHC Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, GEHC has a market cap of 29B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while GEHC trades at $64.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas GEHC's P/E ratio is 14.06. In terms of profitability, KIDS's ROE is -0.12%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, KIDS is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
KIDS vs PHG Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PHG has a market cap of 24.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PHG trades at $24.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PHG's P/E ratio is 14.10. In terms of profitability, KIDS's ROE is -0.12%, compared to PHG's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
KIDS vs ZBH Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ZBH has a market cap of 18.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ZBH trades at $95.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ZBH's P/E ratio is 11.25. In terms of profitability, KIDS's ROE is -0.12%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, KIDS is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
KIDS vs ABMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ABMD's P/E ratio is 65.36. In terms of profitability, KIDS's ROE is -0.12%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
KIDS vs SWAV Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SWAV's P/E ratio is 78.76. In terms of profitability, KIDS's ROE is -0.12%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, KIDS is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
KIDS vs PEN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PEN trades at $317.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PEN's P/E ratio is 82.93. In terms of profitability, KIDS's ROE is -0.12%, compared to PEN's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
KIDS vs SNN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SNN has a market cap of 11.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SNN trades at $27.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SNN's P/E ratio is 12.97. In terms of profitability, KIDS's ROE is -0.12%, compared to SNN's ROE of +0.12%. Regarding short-term risk, KIDS is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
KIDS vs ALGN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ALGN has a market cap of 10.7B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ALGN trades at $147.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ALGN's P/E ratio is 13.65. In terms of profitability, KIDS's ROE is -0.12%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, KIDS is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
KIDS vs BIO-B Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BIO-B has a market cap of 10.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BIO-B trades at $385.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BIO-B's P/E ratio is -67.94. In terms of profitability, KIDS's ROE is -0.12%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, KIDS is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
KIDS vs BIO Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BIO has a market cap of 10.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BIO trades at $376.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BIO's P/E ratio is 40.53. In terms of profitability, KIDS's ROE is -0.12%, compared to BIO's ROE of +0.03%. Regarding short-term risk, KIDS is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
KIDS vs GMED Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, GMED has a market cap of 10B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while GMED trades at $74.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas GMED's P/E ratio is 16.69. In terms of profitability, KIDS's ROE is -0.12%, compared to GMED's ROE of +0.12%. Regarding short-term risk, KIDS is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check GMED's competition here
Insulet Corp. (NASDAQ: PODD)
KIDS vs PODD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PODD has a market cap of 9.7B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PODD trades at $140.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PODD's P/E ratio is 23.95. In terms of profitability, KIDS's ROE is -0.12%, compared to PODD's ROE of +0.27%. Regarding short-term risk, KIDS is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PODD's competition here
Glaukos Corporation (NYSE: GKOS)
KIDS vs GKOS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, GKOS has a market cap of 9.7B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while GKOS trades at $163.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas GKOS's P/E ratio is -190.27. In terms of profitability, KIDS's ROE is -0.12%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, KIDS is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check GKOS's competition here
Masimo Corporation (NASDAQ: MASI)
KIDS vs MASI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas MASI's P/E ratio is 44.43. In terms of profitability, KIDS's ROE is -0.12%, compared to MASI's ROE of +0.09%. Regarding short-term risk, KIDS is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
KIDS vs BRKR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BRKR trades at $61.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BRKR's P/E ratio is 30.85. In terms of profitability, KIDS's ROE is -0.12%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, KIDS is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
KIDS vs BRKRP Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BRKRP has a market cap of 9B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BRKRP trades at $447.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BRKRP's P/E ratio is 245.01. In terms of profitability, KIDS's ROE is -0.12%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, KIDS is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
KIDS vs HAE Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while HAE trades at $108.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas HAE's P/E ratio is 21.66. In terms of profitability, KIDS's ROE is -0.12%, compared to HAE's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
KIDS vs NARI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NARI's P/E ratio is -59.24. In terms of profitability, KIDS's ROE is -0.12%, compared to NARI's ROE of -0.00%. Regarding short-term risk, KIDS is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
KIDS vs ITGR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ITGR trades at $126.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ITGR's P/E ratio is 19.90. In terms of profitability, KIDS's ROE is -0.12%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, KIDS is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
KIDS vs LIVN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while LIVN trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas LIVN's P/E ratio is 18.53. In terms of profitability, KIDS's ROE is -0.12%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, KIDS is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
KIDS vs AXNX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AXNX's P/E ratio is -709.80. In terms of profitability, KIDS's ROE is -0.12%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
KIDS vs IRTC Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while IRTC trades at $109.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas IRTC's P/E ratio is -254.26. In terms of profitability, KIDS's ROE is -0.12%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, KIDS is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check IRTC's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
KIDS vs TMDX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while TMDX trades at $86.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas TMDX's P/E ratio is 43.87. In terms of profitability, KIDS's ROE is -0.12%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, KIDS is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
KIDS vs NEOG Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NEOG trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NEOG's P/E ratio is 46.39. In terms of profitability, KIDS's ROE is -0.12%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, KIDS is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
KIDS vs AXGN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AXGN has a market cap of 2.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AXGN trades at $44.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AXGN's P/E ratio is 116.39. In terms of profitability, KIDS's ROE is -0.12%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, KIDS is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
KIDS vs INSP Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, INSP has a market cap of 2.2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while INSP trades at $76.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas INSP's P/E ratio is 33.84. In terms of profitability, KIDS's ROE is -0.12%, compared to INSP's ROE of +0.18%. Regarding short-term risk, KIDS is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check INSP's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
KIDS vs UFPT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, UFPT has a market cap of 2.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while UFPT trades at $276.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas UFPT's P/E ratio is 28.26. In terms of profitability, KIDS's ROE is -0.12%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, KIDS is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
KIDS vs BFLY Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BFLY has a market cap of 2.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BFLY trades at $7.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BFLY's P/E ratio is -32.81. In terms of profitability, KIDS's ROE is -0.12%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, KIDS is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
KIDS vs NUVA Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NUVA's P/E ratio is 75.00. In terms of profitability, KIDS's ROE is -0.12%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, KIDS is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
KIDS vs ESTA Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ESTA trades at $69.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ESTA's P/E ratio is -55.00. In terms of profitability, KIDS's ROE is -0.12%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, KIDS is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
KIDS vs NVCR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NVCR trades at $16.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NVCR's P/E ratio is -12.84. In terms of profitability, KIDS's ROE is -0.12%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, KIDS is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
KIDS vs ATEC Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ATEC trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ATEC's P/E ratio is -169.67. In terms of profitability, KIDS's ROE is -0.12%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, KIDS is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
KIDS vs CNMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CNMD trades at $45.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CNMD's P/E ratio is 10.00. In terms of profitability, KIDS's ROE is -0.12%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, KIDS is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
KIDS vs HSKA Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas HSKA's P/E ratio is -62.49. In terms of profitability, KIDS's ROE is -0.12%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, KIDS is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
KIDS vs IART Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while IART trades at $15.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas IART's P/E ratio is 6.45. In terms of profitability, KIDS's ROE is -0.12%, compared to IART's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
KIDS vs AVNS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AVNS's P/E ratio is 27.77. In terms of profitability, KIDS's ROE is -0.12%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, KIDS is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
KIDS vs TNDM Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while TNDM trades at $16.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas TNDM's P/E ratio is -18.14. In terms of profitability, KIDS's ROE is -0.12%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, KIDS is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check TNDM's competition here
Artivion, Inc. (NYSE: AORT)
KIDS vs AORT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AORT trades at $23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AORT's P/E ratio is 38.85. In terms of profitability, KIDS's ROE is -0.12%, compared to AORT's ROE of -0.01%. Regarding short-term risk, KIDS is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AORT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
KIDS vs SILK Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SILK's P/E ratio is -18.96. In terms of profitability, KIDS's ROE is -0.12%, compared to SILK's ROE of -0.35%. Regarding short-term risk, KIDS is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
KIDS vs FNA Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas FNA's P/E ratio is -19.83. In terms of profitability, KIDS's ROE is -0.12%, compared to FNA's ROE of -0.35%. Regarding short-term risk, KIDS is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check FNA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
KIDS vs PRCT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PRCT trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PRCT's P/E ratio is -9.95. In terms of profitability, KIDS's ROE is -0.12%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, KIDS is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
KIDS vs LMRI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while LMRI trades at $11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas LMRI's P/E ratio is -21.56. In terms of profitability, KIDS's ROE is -0.12%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, KIDS is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check LMRI's competition here
IRadimed Corporation (NASDAQ: IRMD)
KIDS vs IRMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, IRMD has a market cap of 1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while IRMD trades at $82.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas IRMD's P/E ratio is 41.27. In terms of profitability, KIDS's ROE is -0.12%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, KIDS is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check IRMD's competition here
Enovis Corporation (NYSE: ENOV)
KIDS vs ENOV Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ENOV trades at $18.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ENOV's P/E ratio is 5.17. In terms of profitability, KIDS's ROE is -0.12%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, KIDS is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ENOV's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
KIDS vs BBNX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BBNX has a market cap of 984.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BBNX trades at $21.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BBNX's P/E ratio is -13.27. In terms of profitability, KIDS's ROE is -0.12%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, KIDS is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
KIDS vs CBLL Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CBLL has a market cap of 924.7M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CBLL trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CBLL's P/E ratio is -13.85. In terms of profitability, KIDS's ROE is -0.12%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, KIDS is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
KIDS vs BVS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BVS has a market cap of 874.6M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BVS trades at $12.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BVS's P/E ratio is 16.99. In terms of profitability, KIDS's ROE is -0.12%, compared to BVS's ROE of +0.28%. Regarding short-term risk, KIDS is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BVS's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
KIDS vs CSII Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CSII's P/E ratio is -20.83. In terms of profitability, KIDS's ROE is -0.12%, compared to CSII's ROE of -0.14%. Regarding short-term risk, KIDS is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
KIDS vs INMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, INMD has a market cap of 824.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while INMD trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas INMD's P/E ratio is 9.97. In terms of profitability, KIDS's ROE is -0.12%, compared to INMD's ROE of +0.12%. Regarding short-term risk, KIDS is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check INMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
KIDS vs SIBN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SIBN has a market cap of 802.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SIBN trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SIBN's P/E ratio is -53.21. In terms of profitability, KIDS's ROE is -0.12%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, KIDS is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
KIDS vs AVR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AVR has a market cap of 793.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AVR trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AVR's P/E ratio is -4.21. In terms of profitability, KIDS's ROE is -0.12%, compared to AVR's ROE of -0.78%. Regarding short-term risk, KIDS is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AVR's competition here
Varex Imaging Corporation (NASDAQ: VREX)
KIDS vs VREX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while VREX trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas VREX's P/E ratio is 19.46. In terms of profitability, KIDS's ROE is -0.12%, compared to VREX's ROE of +0.05%. Regarding short-term risk, KIDS is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
KIDS vs AHCO Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, AHCO has a market cap of 776.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while AHCO trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas AHCO's P/E ratio is 11.65. In terms of profitability, KIDS's ROE is -0.12%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, KIDS is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
KIDS vs CTKB Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CTKB has a market cap of 684.5M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CTKB trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CTKB's P/E ratio is -28.08. In terms of profitability, KIDS's ROE is -0.12%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, KIDS is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CTKB's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
KIDS vs SSII Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SSII has a market cap of 652.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SSII trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SSII's P/E ratio is -63.58. In terms of profitability, KIDS's ROE is -0.12%, compared to SSII's ROE of -0.27%. Regarding short-term risk, KIDS is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
KIDS vs SRDX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SRDX's P/E ratio is -34.66. In terms of profitability, KIDS's ROE is -0.12%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, KIDS is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
KIDS vs APEN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas APEN's P/E ratio is -9.43. In terms of profitability, KIDS's ROE is -0.12%, compared to APEN's ROE of -0.85%. Regarding short-term risk, KIDS is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
KIDS vs DCTH Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, DCTH has a market cap of 556.1M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while DCTH trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas DCTH's P/E ratio is 1611.00. In terms of profitability, KIDS's ROE is -0.12%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, KIDS is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
KIDS vs ZIMV Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, KIDS's ROE is -0.12%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
KIDS vs CERS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CERS has a market cap of 534M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CERS trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CERS's P/E ratio is -52.89. In terms of profitability, KIDS's ROE is -0.12%, compared to CERS's ROE of -0.10%. Regarding short-term risk, KIDS is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
KIDS vs TCMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, TCMD has a market cap of 500.7M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while TCMD trades at $22.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas TCMD's P/E ratio is 20.56. In terms of profitability, KIDS's ROE is -0.12%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
KIDS vs NPCE Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NPCE has a market cap of 486.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NPCE trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NPCE's P/E ratio is -25.05. In terms of profitability, KIDS's ROE is -0.12%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, KIDS is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
KIDS vs SGHT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SGHT has a market cap of 436.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SGHT trades at $8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SGHT's P/E ratio is -14.32. In terms of profitability, KIDS's ROE is -0.12%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, KIDS is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SGHT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
KIDS vs PACB Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PACB has a market cap of 425.5M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PACB trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PACB's P/E ratio is -3.34. In terms of profitability, KIDS's ROE is -0.12%, compared to PACB's ROE of -49.62%. Regarding short-term risk, KIDS is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PACB's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
KIDS vs CLPT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CLPT has a market cap of 414.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CLPT trades at $13.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CLPT's P/E ratio is -11.72. In terms of profitability, KIDS's ROE is -0.12%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, KIDS is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
KIDS vs SENS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SENS has a market cap of 400.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SENS trades at $9.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SENS's P/E ratio is -4.30. In terms of profitability, KIDS's ROE is -0.12%, compared to SENS's ROE of -1.66%. Regarding short-term risk, KIDS is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
KIDS vs OFIX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, OFIX has a market cap of 352.1M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while OFIX trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas OFIX's P/E ratio is -5.67. In terms of profitability, KIDS's ROE is -0.12%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, KIDS is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
KIDS vs CV Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CV has a market cap of 334.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CV trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CV's P/E ratio is -10.63. In terms of profitability, KIDS's ROE is -0.12%, compared to CV's ROE of -1.78%. Regarding short-term risk, KIDS is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
KIDS vs CATX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, CATX has a market cap of 327.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while CATX trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas CATX's P/E ratio is -2.16. In terms of profitability, KIDS's ROE is -0.12%, compared to CATX's ROE of -0.42%. Regarding short-term risk, KIDS is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
KIDS vs TLSI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, TLSI has a market cap of 314M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while TLSI trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas TLSI's P/E ratio is -3.04. In terms of profitability, KIDS's ROE is -0.12%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, KIDS is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
KIDS vs SMLR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas SMLR's P/E ratio is 3.92. In terms of profitability, KIDS's ROE is -0.12%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, KIDS is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
KIDS vs TMCI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, TMCI has a market cap of 291.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while TMCI trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas TMCI's P/E ratio is -4.78. In terms of profitability, KIDS's ROE is -0.12%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, KIDS is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
KIDS vs RCEL Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, RCEL has a market cap of 273.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while RCEL trades at $11.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas RCEL's P/E ratio is -7.65. In terms of profitability, KIDS's ROE is -0.12%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, KIDS is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
KIDS vs INFU Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, INFU has a market cap of 258.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while INFU trades at $12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas INFU's P/E ratio is 31.22. In terms of profitability, KIDS's ROE is -0.12%, compared to INFU's ROE of +0.15%. Regarding short-term risk, KIDS is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
KIDS vs MGRM Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas MGRM's P/E ratio is -12.00. In terms of profitability, KIDS's ROE is -0.12%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, KIDS is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
KIDS vs NVRO Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas NVRO's P/E ratio is -1.91. In terms of profitability, KIDS's ROE is -0.12%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, KIDS is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
KIDS vs ELMD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ELMD has a market cap of 218.5M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ELMD trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ELMD's P/E ratio is 20.15. In terms of profitability, KIDS's ROE is -0.12%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, KIDS is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ELMD's competition here
RxSight, Inc. (NASDAQ: RXST)
KIDS vs RXST Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, RXST has a market cap of 215.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while RXST trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas RXST's P/E ratio is -4.60. In terms of profitability, KIDS's ROE is -0.12%, compared to RXST's ROE of -0.17%. Regarding short-term risk, KIDS is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
KIDS vs PROF Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, PROF has a market cap of 212.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while PROF trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas PROF's P/E ratio is -5.98. In terms of profitability, KIDS's ROE is -0.12%, compared to PROF's ROE of -0.56%. Regarding short-term risk, KIDS is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PROF's competition here
Neuronetics, Inc. (NASDAQ: STIM)
KIDS vs STIM Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, STIM has a market cap of 201.8M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while STIM trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas STIM's P/E ratio is -6.59. In terms of profitability, KIDS's ROE is -0.12%, compared to STIM's ROE of -1.51%. Regarding short-term risk, KIDS is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
KIDS vs BSGM Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas BSGM's P/E ratio is -5.81. In terms of profitability, KIDS's ROE is -0.12%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, KIDS is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
KIDS vs MDGS Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas MDGS's P/E ratio is -0.27. In terms of profitability, KIDS's ROE is -0.12%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, KIDS is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
KIDS vs QIPT Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas QIPT's P/E ratio is -15.87. In terms of profitability, KIDS's ROE is -0.12%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, KIDS is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
KIDS vs FOCL Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, FOCL has a market cap of 155.6M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while FOCL trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas FOCL's P/E ratio is -4.01. In terms of profitability, KIDS's ROE is -0.12%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, KIDS is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check FOCL's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
KIDS vs LUCD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, LUCD has a market cap of 149.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while LUCD trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas LUCD's P/E ratio is -2.12. In terms of profitability, KIDS's ROE is -0.12%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, KIDS is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
KIDS vs QSI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, QSI has a market cap of 147.4M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while QSI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas QSI's P/E ratio is -1.62. In terms of profitability, KIDS's ROE is -0.12%, compared to QSI's ROE of -0.47%. Regarding short-term risk, KIDS is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check QSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
KIDS vs QTRX Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, QTRX has a market cap of 144.6M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while QTRX trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas QTRX's P/E ratio is -1.21. In terms of profitability, KIDS's ROE is -0.12%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, KIDS is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
KIDS vs INGN Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, INGN has a market cap of 139.2M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while INGN trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas INGN's P/E ratio is -5.65. In terms of profitability, KIDS's ROE is -0.12%, compared to INGN's ROE of -0.13%. Regarding short-term risk, KIDS is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
KIDS vs ICAD Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ICAD's P/E ratio is -20.37. In terms of profitability, KIDS's ROE is -0.12%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, KIDS is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
KIDS vs ECOR Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ECOR has a market cap of 105.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ECOR trades at $11.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ECOR's P/E ratio is -6.95. In terms of profitability, KIDS's ROE is -0.12%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, KIDS is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
KIDS vs HJLI Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas HJLI's P/E ratio is N/A. In terms of profitability, KIDS's ROE is -0.12%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, KIDS is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
KIDS vs ASXC Comparison September 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 560.4M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, KIDS is priced at $21.82 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -18.49, whereas ASXC's P/E ratio is -1.12. In terms of profitability, KIDS's ROE is -0.12%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, KIDS is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ASXC's competition here